A citation-based method for searching scientific literature

Lise L Kjems, Jens J Holst, Aage Vølund, Sten Madsbad. Diabetes 2003
Times Cited: 411



Darleen A Sandoval, David A D'Alessio. Physiol Rev 2015
Times Cited: 194




List of shared articles



Times cited

Incretin Hormones in Obesity and Related Cardiometabolic Disorders: The Clinical Perspective.
Joanna Michałowska, Ewa Miller-Kasprzak, Paweł Bogdański. Nutrients 2021
3

Mutational Landscape of the Proglucagon-Derived Peptides.
Peter Lindquist, Jakob S Madsen, Hans Bräuner-Osborne, Mette M Rosenkilde, Alexander S Hauser. Front Endocrinol (Lausanne) 2021
1


Incretins in obesity and diabetes.
Chee W Chia, Josephine M Egan. Ann N Y Acad Sci 2020
19

Neuroprotective Actions of Glucagon-Like Peptide-1 (GLP-1) Analogues in Alzheimer's and Parkinson's Diseases.
Andre F Batista, Victor Bodart-Santos, Fernanda G De Felice, Sergio T Ferreira. CNS Drugs 2019
26

The Impact of a Large Bolus Dose of l-leucine and l-isoleucine on Enteroendocrine and Pancreatic Hormones, and Glycemia in Healthy, Inactive Adults.
Daniel E Newmire, Eric Rivas, Sarah E Deemer, Darryn S Willoughby, Victor Ben-Ezra. Nutrients 2019
1

Glucagon-like peptide 1 in health and disease.
Andreas Andersen, Asger Lund, Filip K Knop, Tina Vilsbøll. Nat Rev Endocrinol 2018
136

Clinical pharmacology of glucagon-like peptide-1 receptor agonists.
Dimitrios Sfairopoulos, Stavros Liatis, Stelios Tigas, Evangelos Liberopoulos. Hormones (Athens) 2018
22

Ghrelin, CCK, GLP-1, and PYY(3-36): Secretory Controls and Physiological Roles in Eating and Glycemia in Health, Obesity, and After RYGB.
Robert E Steinert, Christine Feinle-Bisset, Lori Asarian, Michael Horowitz, Christoph Beglinger, Nori Geary. Physiol Rev 2017
217